Abound Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.9K | Buy |
679
+447
| +193% | +$48K | 0.02% | 158 |
|
|
2025
Q1 | $23.4K | Sell |
232
-75
| -24% | -$7.56K | 0.01% | 273 |
|
|
2024
Q4 | $27.4K | Sell |
307
-41
| -12% | -$3.66K | 0.01% | 240 |
|
|
2024
Q3 | $29.1K | Buy |
348
+74
| +27% | +$6.2K | 0.01% | 235 |
|
|
2024
Q2 | $21.1K | Sell |
274
-61
| -18% | -$4.69K | 0.01% | 244 |
|
|
2024
Q1 | $22.9K | Buy |
335
+67
| +25% | +$4.58K | 0.01% | 222 |
|
|
2023
Q4 | $15.5K | Sell |
268
-22
| -8% | -$1.27K | 0.01% | 311 |
|
|
2023
Q3 | $15.3K | Buy |
290
+50
| +21% | +$2.64K | 0.01% | 256 |
|
|
2023
Q2 | $13K | Buy |
240
+14
| +6% | +$757 | 0.01% | 293 |
|
|
2023
Q1 | $11.3K | Buy |
226
+63
| +39% | +$3.15K | 0.01% | 274 |
|
|
2022
Q4 | $7.54K | Sell |
163
-20
| -11% | -$926 | ﹤0.01% | 296 |
|
|
2022
Q3 | $7.09K | Buy |
+183
| New | +$7.09K | ﹤0.01% | 320 |
|